Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Net Margin (2016 - 2025)

Orthofix Medical's Net Margin history spans 16 years, with the latest figure at 1.01% for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 1677.0% year-over-year to 1.01%, compared with a TTM value of 11.37% through Dec 2025, up 608.0%, and an annual FY2025 reading of 11.21%, up 564.0% over the prior year.
  • Net Margin for Q4 2025 was 1.01% at Orthofix Medical, up from 11.09% in the prior quarter.
  • The five-year high for Net Margin was 2.11% in Q2 2022, with the low at 38.25% in Q4 2021.
  • Average Net Margin over 5 years is 13.4%, with a median of 10.93% recorded in 2023.
  • Biggest YoY gain for Net Margin was 3150bps in 2021; the steepest drop was -4005bps in 2021.
  • Tracing OFIX's Net Margin over 5 years: stood at 38.25% in 2021, then surged by 77bps to 8.88% in 2022, then dropped by -21bps to 10.78% in 2023, then plummeted by -65bps to 17.78% in 2024, then surged by 94bps to 1.01% in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Net Margin are 1.01% (Q4 2025), 11.09% (Q3 2025), and 7.36% (Q2 2025).